Testing Data
(Gel: 8%SDS-PAGE Lysates (from left to right): A172 and A549 cell Amount of lysate: 40ug per lane Primary antibody: 1/950 dilution Secondary antibody dilution: 1/8000 Exposure time: 1 minute)
Rabbit anti-Human CHRNA2 Polyclonal Antibody | anti-CHRNA2 antibody
CHRNA2 Antibody
Immunohistochemistry: 1:25-1:100
Testing Data
(Gel: 8%SDS-PAGE Lysates (from left to right): A172 and A549 cell Amount of lysate: 40ug per lane Primary antibody: 1/950 dilution Secondary antibody dilution: 1/8000 Exposure time: 1 minute)
Testing Data
(Gel: 8%SDS-PAGE Lysates (from left to right): A172 and A549 cell Amount of lysate: 40ug per lane Primary antibody: 1/950 dilution Secondary antibody dilution: 1/8000 Exposure time: 1 minute)
Immunohistochemistry (IHC)
(Immunohistochemical analysis of paraffin-embedded Human cervical cancer tissue using at dilution 1/40.)
Immunohistochemistry (IHC)
(Immunohistochemical analysis of paraffin-embedded Human cervical cancer tissue using at dilution 1/40.)
NCBI and Uniprot Product Information
NCBI Description
Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels formed by a pentameric arrangement of alpha and beta subunits to create distinct muscle and neuronal receptors. Neuronal receptors are found throughout the peripheral and central nervous system where they are involved in fast synaptic transmission. This gene encodes an alpha subunit that is widely expressed in the brain. The proposed structure for nAChR subunits is a conserved N-terminal extracellular domain followed by three conserved transmembrane domains, a variable cytoplasmic loop, a fourth conserved transmembrane domain, and a short C-terminal extracellular region. Mutations in this gene cause autosomal dominant nocturnal frontal lobe epilepsy type 4. Single nucleotide polymorphisms (SNPs) in this gene have been associated with nicotine dependence. [provided by RefSeq, Nov 2009]
Uniprot Description
nAChRA2: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. Defects in CHRNA2 are the cause of nocturnal frontal lobe epilepsy type 4 (ENFL4). ENFL4 is an autosomal dominant epilepsy characterized by nocturnal seizures associated with fear sensation, tongue movements, and nocturnal wandering, closely resembling nightmares and sleep walking. Belongs to the ligand-gated ion channel (TC 1.A.9) family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha- 2/CHRNA2 sub-subfamily.
Protein type: Membrane protein, multi-pass; Channel, cation; Receptor, misc.; Channel, ligand-gated; Membrane protein, integral
Chromosomal Location of Human Ortholog: 8p21
Cellular Component: nicotinic acetylcholine-gated receptor-channel complex; postsynaptic membrane; plasma membrane; integral to membrane; cell junction
Molecular Function: acetylcholine receptor activity; drug binding; acetylcholine binding; nicotinic acetylcholine-activated cation-selective channel activity
Biological Process: synaptic transmission; protein heterooligomerization; ion transport; signal transduction; cation transport
Disease: Epilepsy, Nocturnal Frontal Lobe, 4
Research Articles on CHRNA2
Similar Products
Product Notes
The CHRNA2 chrna2 (Catalog #AAA9404514) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The CHRNA2 Antibody reacts with Human and may cross-react with other species as described in the data sheet. AAA Biotech's CHRNA2 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC). Western blotting: 1:500-1:2000 Immunohistochemistry: 1:25-1:100. Researchers should empirically determine the suitability of the CHRNA2 chrna2 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "CHRNA2, Polyclonal Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.
